CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD

Andere talen Chengdu Kanghong Pharmaceutical Group Co., Ltd

Aandelen

002773

CNE1000020C4

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 03-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
22,1 ^CNY	-1,12%		-2,26%	+19,85%

22/05	Chengdu Kanghong Pharmaceutical Group Co, Ltd kondigt een slotdividend in contanten aan op A-aandelen voor het jaar 2023, betaalbaar op 28 mei 2024	CI
29/04	Eenheid van Kanghong Pharmaceutical krijgt groen licht van de Amerikaanse FDA om medicijn tegen maculadegeneratie te testen	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 May 2024	22/05
Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug	29/04
Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug	29/04
Chengdu Kanghong Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2023	25/04
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	24/04
Kanghong Pharmaceutical's Beijing Unit Gets China's Approval for Clinical Trials for Anti-Tumor Injection	06/03
Kanghong Pharmaceutical's Unit Gets Nod to Trial Psoriasis Drug	28/02
Kanghong Pharmaceutical Gets Nod for Registration of Escitalopram Oxalate Tablets	12/12
Kanghong Pharma's Aripiprazole Oral Solution Chosen for China's Centralized Drug Procurement	08/11
Kanghong Pharma Gets FDA Nod to Trial Drug Against Fatty Liver Disease	06/11
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
Kanghong Pharmaceutical Gets US FDA's Clinical Trial Nod for Antidepressant	24-10-23
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	27-08-23
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Executive Changes	04-08-23
Kanghong Pharma Gets Nod to Trial Antidepressant	20-07-23
Kanghong Pharma Gets Continued Protection for Traditional Chinese Medicine	20-06-23
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on Share A for 2022, Payable on June 6, 2023	30-05-23
Chengdu Kanghong Pharmaceutical Group Co., Ltd Approves Cash Dividend for the Year 2022	24-05-23
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Chengdu Kanghong Pharmaceutical Group Co., Ltd

Aandelen

002773

CNE1000020C4

Andere talen

Filters